185
Views
11
CrossRef citations to date
0
Altmetric
Review

Red cell distribution width to platelet ratio for liver fibrosis: a systematic review and meta-analysis of diagnostic accuracy

, &
Pages 877-891 | Received 20 Mar 2019, Accepted 06 Aug 2019, Published online: 12 Aug 2019

References

  • Haghgoo SM, Sharafi H, Alavian SM. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review. Clin Chem Lab Med. 2018. DOI:10.1515/cclm-2018-0357
  • Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349:825–832.
  • Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209–218.
  • Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749–1761.
  • Salvagno GL, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52:86–105.
  • Zhang T, Li J, Lin Y, et al. Association between red blood cell distribution width and all-cause mortality in chronic kidney disease patients: a systematic review and meta-analysis. Arch Med Res. 2017;48:378–385.
  • Su C, Liao L-Z, Song Y, et al. The role of red blood cell distribution width in mortality and cardiovascular risk among patients with coronary artery diseases: a systematic review and meta-analysis. J Thorac Dis. 2014;6:1429–1440.
  • Patel KV, Semba RD, Ferrucci L, et al. Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol Ser A Biol Sci Med Sci. 2010;65A:258–265.
  • Ai L, Mu S, Hu Y. Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis. Cancer Cell Int. 2018;18:61.
  • Xu W-Y, Yang X-B, Wang W-Q, et al. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis. World J Gastroenterol. 2018;24:2120–2129.
  • Hu L, Li M, Ding Y, et al. Prognostic value of RDW in cancers: a systematic review and meta-analysis. Oncotarget. 2017;8:16027–16035.
  • Ganji A, Esmaeilzadeh A, Ghanaei O, et al. Predictive value of red blood cell distribution width for mortality in patients with acute pancreatitis: A systematic review and meta-analysis. Med J Islam Repub Iran. 2017;31:823–828.
  • Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol. 2009;15:4653–4658.
  • Viswanath D, Hegde R, Murthy V, et al. Red cell distribution width in the diagnosis of iron deficiency anemia. Indian J Pediatr. 2001;68:1117–1119. [cited 2019 Jan 31]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11838564
  • Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 2006;4:236–241. [cited 2019 Jan 31]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16988104
  • Gupta PK, Saxena R, Karan AS, et al. Red cell indices for distinguishing macrocytosis of aplastic anaemia and megaloblastic anaemia. Indian J Pathol Microbiol. 2003;46:375–377. [cited 2019 Jan 31]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15025277
  • Fan X, Deng H, Wang X, et al. Association of red blood cell distribution width with severity of hepatitis B virus-related liver diseases. Clin Chim Acta. 2018;482:155–160.
  • Goyal H, Hu Z-D. Prognostic value of red blood cell distribution width in hepatocellular carcinoma. Ann Transl Med. 2017;5:271.
  • Mitchell O, Feldman DM, Diakow M, et al. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016;8:39–50.
  • Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol. 2017;23:3228–3239.
  • Afdhal N, McHutchison J, Brown R, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008;48:1000–1007.
  • Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol. 2000;14(Suppl D):60D–66D. [cited 2019 Jan 31]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11110614
  • Cetinkaya E, Senol K, Saylam B, et al. Red cell distribution width to platelet ratio: new and promising prognostic marker in acute pancreatitis. World J Gastroenterol. 2014;20:14450–14454.
  • Celik T, Balta S, Mikhailidis DP, et al. The relation between no-reflow phenomenon and complete blood count parameters. Angiology. 2017;68:381–388.
  • Ilhan G, Atmaca FFV, Altan E, et al. Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and red blood cell distribution width-platelet ratio for diagnosis of premature ovarian insufficiency. J Fam Reprod Heal. 2016;10:211–216. [cited 2019 Jan 31]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28546821
  • Xie S, Chen X. Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus. Medicine (Baltimore). 2018;97:e12342.
  • Chang PE, Goh G-B-B, Ngu JH, et al. Clinical applications, limitations and future role of transient elastography in the management of liver disease. World J Gastrointest Pharmacol Ther. 2016;7:91–106.
  • Fedorov S. GetData graph digitizer. 2014. Available from: http://getdata-graph-digitizer.com
  • Levis B, Benedetti A, Levis AW, et al. Selective cutoff reporting in studies of diagnostic test accuracy: a comparison of conventional and individual-patient-data meta-analyses of the patient health questionnaire-9 depression screening tool. Am J Epidemiol. 2017;185:954–964.
  • Ensor J, Deeks JJ, Martin EC, et al. Meta-analysis of test accuracy studies using imputation for partial reporting of multiple thresholds. Res Synth Methods. 2018;9:100–115.
  • Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529.
  • The Cochrane Collaboration. Review manager (RevMan). 2014. Available from: https://community.cochrane.org/help/tools-and-software/revman-5
  • Chen B, Ye B, Zhang J, et al. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS One. 2013;8:1–8.
  • Cengiz M, Ozenirler S. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2015;27:1293–1299.
  • Jiang X, Wang Y, Su Z, et al. Red blood cell distribution width to platelet ratio levels in assessment of histologic severity in patients with primary biliary cholangitis. Scand J Clin Lab Invest. 2018;78:258–263.
  • Taefi A, Huang CC, Kolli K, et al. Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients. Hepatol Int. 2015;9:454–460.
  • Wang H, Xu H, Qu L, et al. Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients. Eur J Gastroenterol Hepatol. 2016;28:997–1002.
  • Wang H, Xu H, Wang X, et al. Red blood cell distribution width to platelet ratio is related to histologic severity of primary biliary cirrhosis. Med. 2016;95:1–6.
  • Wu X, Cai B, Su Z, et al. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepati. J Clin Lab Anal. 2018;32:1–8.
  • Zhu MY, Zou X, Li Q, et al. A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection. J Viral Hepat. 2017;24:589–598.
  • Reitsma JB, Glas AS, Rutjes AWS, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58:982–990.
  • Walter SD. The partial area under the summary ROC curve. Stat Med. 2005;24:2025–2040.
  • Fagan TJ. Nomogram for Bayes’s Theorem. N Engl J Med. 1975;293:257.
  • Galbraith RF. Some applications of radial plots. J Am Stat Assoc. 1994;89:1232–1242.
  • Galbraith RF. Graphical display of estimates having differing standard errors. Technometrics. 1988;30:271–281.
  • Lau J, Ioannidis JPA, Terrin N, et al. The case of the misleading funnel plot. BMJ. 2006;333:597–600.
  • Steinhauser S, Schumacher M, Rücker G. Modelling multiple thresholds in meta-analysis of diagnostic test accuracy studies. BMC Med Res Methodol. 2016;16:97.
  • Martínez-Camblor P. Fully non-parametric receiver operating characteristic curve estimation for random-effects meta-analysis. Stat Methods Med Res. 2017;26:5–20.
  • Ferdous A, AN A, Rahman SA, et al. Role of red cell distribution width to platelet ratio in predicting hepatic fibrosis in chronic hepatitis B. Mymensingh Med J. 2018;27:550–560. [cited 2019 Jan 31]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30141445
  • Cengiz M, Candır BA, Yılmaz G, et al. Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage? World J Gastroenterol. 2013;19:7412–7418.
  • Hu Z, Sun Y, Wang Q, et al. Red blood cell distribution width is a potential prognostic index for liver disease. Clin Chem Lab Med. 2013;51:1403–1408.
  • Huang R, Yang C, Wu K, et al. Red cell distribution width as a potential index to assess the severity of hepatitis B virus-related liver diseases. Hepatol Res. 2014;44:E464–70.
  • Kim HM, Kim BS, Cho YK, et al. Elevated red cell distribution width is associated with advanced fibrosis in NAFLD. Clin Mol Hepatol. 2013;19:258–265.
  • Wang D, Wang Q, Shan F, et al. Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers. BMC Infect Dis. 2010;10:251.
  • Wai C, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–526.
  • Sebastiani G, Castera L, Halfon P, et al. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther. 2011;34:1202–1216.
  • Parikh P, Ryan JD, Tsochatzis EA. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Ann Transl Med. 2017;5:40.
  • Guha IN, Rosenberg WM. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. Clin Liver Dis. 2008;12:883–900.
  • Chwist A, Hartleb M, Lekstan A, et al. A composite model including visfatin, tissue polypeptide-specific antigen, hyaluronic acid, and hematological variables for the diagnosis of moderate-to-severe fibrosis in nonalcoholic fatty liver disease: a preliminary study. Pol Arch Med Wewn. 2014;124:704–712. [cited 2019 Jan 31]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25394651
  • Chen J, Liu C, Chen H, et al. Study on noninvasive laboratory tests for fibrosis in chronic HBV infection and their evaluation. J Clin Lab Anal. 2013;27:5–11.
  • Thandassery RB, Al Kaabi S, Soofi ME, et al. Mean platelet volume, red cell distribution width to platelet count ratio, globulin platelet index, and 16 other indirect noninvasive fibrosis scores: how much do routine blood tests tell about liver fibrosis in chronic hepatitis C? J Clin Gastroenterol. 2016;50:518–523.
  • Wang J, Yan X, Yang Y, et al. A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B. Oncotarget. 2017;8:59257–59267.
  • Xu WS, Qiu XM, Ou QS, et al. Red blood cell distribution width levels correlate with liver fibrosis and inflammation a noninvasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis b. Med. 2015;94:1–7.
  • Chen YP, Hu XM, Liang XE, et al. Stepwise application of fibrosis index based on four factors, red cell distribution width–platelet ratio, and aspartate aminotransferase–platelet ratio for compensated hepatitis B fibrosis detection. J Gastroenterol Hepatol. 2018;33:256–263.
  • He Q, He Q, Qin X, et al. The relationship between inflammatory marker levels and hepatitis c virus severity. Gastroenterol Res Pract. 2016;2016. DOI:10.1155/2016/2978479
  • Huang R, Wang G, Tian C, et al. Gamma-glutamyl-Transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China. Sci Rep. 2017;7:1–10.
  • Karagöz E, Tanoǧlu A, Ülçay A, et al. Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. 2016;28:745–748.
  • Karagoz E, Ulcay A, Tanoglu A, et al. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients. Eur J Gastroenterol Hepatol. 2014;26:1320–1324.
  • Lee HW, Kang W, Kim BK, et al. Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis B. Liver Int. 2016;36:24–30.
  • Tag-adeen M, Omar MZ, Abd-elsalam FM, et al. Assessment of liver fi brosis in Egyptian chronic hepatitis B patients. 2018;6. DOI:10.1097/MD.0000000000009781.
  • Fung J, Lai C-L, But D, et al. Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management. Am J Gastroenterol. 2008;103:1421–1426.
  • Setiawan VW, Stram DO, Porcel J, et al. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort. Hepatology. 2016;64:1969–1977.
  • Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol. 2009;50:1–3.
  • Stebbing J, Farouk L, Panos G, et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol. 2010;44:214–219.
  • Li Y, Chen Y, Zhao Y. The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis. PLoS One. 2014;9:e105728.
  • Stevenson M, Lloyd-Jones M, Morgan M, et al. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation. Health Technol Assess (Rockv). 2012;16:1–174.
  • van Katwyk S, Coyle D, Cooper C, et al. Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations. Liver Int. 2017;37:851–861.
  • Sebastiani G, Ghali P, Wong P, et al. Physicians’ practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey. Can J Gastroenterol Hepatol. 2014;28:23–30. [cited 2019 Jan 31]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24416739
  • Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta-analysis. Hepatology. 2015;61:292–302.
  • Yeom SK, Lee CH, Cha SH, et al. Prediction of liver cirrhosis, using diagnostic imaging tools. World J Hepatol. 2015;7:2069.
  • MedCalc statistical software version 16.4.3. MedCalc Softw. bvba, Ostend, Belgium. 2016. Available from: https://www.medcalc.org

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.